EMBLA MEDICAL HF. Announcement from Össur hf. no. 34/2017
Reykjavik, 28 April 2017
According to Article 84 of the Icelandic Act on Securities Transactions No. 108/2007, an issuer shall publish information on its total share capital on the last trading day of the month when the share capital has been decreased.
Össur's total share capital is ISK 437,162,725 nominal value divided into the same number of shares with a nominal value of ISK 1 each following the share capital decrease in April 2017. For further information, see the Company's announcement no. 29/2017 published on 11 April 2017.
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at the following web-site: http://www.ossur.com/investormailings
About Össur
Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports and prosthetic limbs. A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ossur Hf via Globenewswire
